JoVE Journal > Medicine
Summary
Abstract
Introduction
Protocol
Results
Discussion
Disclosures
Acknowledgements
Materials
References
의학

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published: October 18, 2024
doi:
10.3791/66049
, , , , , , , , , , ,
1Jinshazhou Hospital of Guangzhou University of Chinese Medicine, 2General Hospital of Southern Theatre Command, 3Department of Cardiovascular Surgery,Zhujiang Hospital of Southern Medical University, 4Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica,Chinese Academy of Sciences, 5School of Laboratory and Biotechnology,Southern Medical University, 6Guangzhou Hualiang Qingying Biotechnology Co. Ltd

Summary

Duodenal-jejunal bypass (DJB) surgery can improve glucose metabolism and reduce insulin resistance. Here, we present a protocol to establish a stable and reliable mouse model of DJB.

Abstract

The prevalence of obesity and type 2 diabetes is a serious global health concern. Obesity is a major pathogenic factor in type 2 diabetes, cardiovascular disease, and some cancers. Bariatric surgery offers a long-term and effective treatment option for both obesity and diabetes. Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are widely recognized as the most popular bariatric surgeries. Additionally, several exploratory bariatric surgeries have demonstrated promising therapeutic effects. Duodenal-jejunal bypass (DJB), specifically tailored for diabetics with low body mass index, has shown beneficial metabolic outcomes. However, its weight-independent metabolic benefits are not fully understood due to limited animal models. In this article, we describe the optimized care protocols and surgical techniques for performing DJB surgery in diet-induced obese (DIO) diabetic mice. Using a mouse model contributes to a better understanding of the nature of changes induced by DJB surgery while facilitating related clinical practice.

Introduction

Obesity and type 2 diabetes are the most common chronic diseases in the world, and their prevalence is increasing among young individuals1. Bariatric surgery is the most effective treatment for obesity and diabetes, facilitating long-term blood glucose stabilitywhile also improving the complications associated with obesity2,3. There are several types of bariatric surgery, classified by whether they reduce gastric volume or intestinal absorption; these include restrictive, malabsorptive, and combination4,5.

Duodenal-jejunal bypass (DJB) was first developed by Rubino and Marescaux, who demonstrated that type 2 diabetes could be alleviated by connecting the duodenum and jejunum rather than by reducing the gastric volume6,7. DJB preserves the entire stomach and bypasses the entire duodenum and proximal jejunum. The bowel is divided into biliopancreatic, digestive, and common limbs6,8. DJB shares some similarities with bariatric surgeries, including Roux-en-Y gastric bypass (RYGB), mini-gastric bypass, biliopancreatic bypass, duodenal diversion, and DJB plus sleeve gastrectomy9. Compared to RYGB, DJB does not require a gastrointestinal anastomosis, which reduces the operative time and improves the success rate of the procedure. DJB is similar to RYGB in improving glucose metabolism but does not affect body weight10. After DJB surgery, rapid food delivery to the distal small intestine stimulates the secretion of glucagon-like peptide-1 (GLP-1), resulting in improved glucose metabolism11,12.

The use of animal models is essential for understanding the metabolic, cellular, and molecular pathways. Animal models of bariatric surgery have contributed to our understanding of potential mechanisms underlying obesity and diabetes13,14. However, due to the physiological differences between species, it is impossible to perfectly replicate human diseases in animal models15. Among various animal models available for research purposes, the diet-induced obesity (DIO) mouse model most closely resembles human obesity and metabolic syndrome16. Mice were selected for DJB surgery to determine the feasibility of the surgery and to provide techniques for further research. This manuscript provides a comprehensive summary of both technical aspects and experimental details of DJB surgery.

Protocol

All protocol steps described below follow the guidelines of the Animal Care and Use Committee of the General Hospital of the Southern Theater Command under the approval number 2020112501.

1. General preoperative preparation

NOTE: Thirty 6-week-old male C57BL/6 mice were purchased. Mice were housed in a Specific Pathogen-Free (SPF) laboratory under a 12 h light/dark cycle; temperature, 22 ± 2 °C; and humidity, 55-65%. Mice were given free access to water and fed a 60% kcal fat diet for 6 weeks to induce obesity. An intraperitoneal injection of 40 mg/kg streptozotocin was administered for 5 days to induce diabetes17. Among the thirty mice, twenty-two mice were screened for random blood glucose > 300 mg/dL and randomly assigned to the DJB (n=15) and sham surgery (n=7) groups. Eight mice were excluded from the experiment due to substandard blood glucose.

  1. Fast the mice for 8 h prior to the surgery. Withdraw water 2 h before the surgery.
  2. Administer 1% sodium pentobarbital solution (6 mL/kg) and buprenorphine (1 mg/kg) intraperitoneally. Touch the toes or tails of the mice with forceps and ensure that the mice do not show any obvious twitching or shaking. Under adequate anesthesia, the mice can breathe freely without supplemental oxygen.
  3. Place the mice in the supine position on a sterileboardand under a stereomicroscope. Apply eye ointment to the eyes. Use an electric blanket to keep the mice warm throughout the procedure. Use sterile procedures, including surgical gowns, sterile gloves, and autoclaved instruments.
  4. In sham control mice, make the two incisions respectively in the duodenum 1 cm below the pylorus and in the jejunum 5 cm below the Treitz and then suture the incisions.

2. Duodenal jejunal bypass: Surgical Procedure

  1. Apply the depilatory paste from the xiphoid to the abdomen to remove hair from this region. Wipe off the cream and ensure that the skin is clean. Scrub the area three times with alternating scrub of iodine and alcohol solutions.
  2. Cover the mouse with a sterile drape, leaving the operational area exposed, and make a 2 cm incision from the xiphoid to the abdomen.
  3. Use an abdominal retractor to expose the abdominal cavity. Push away the abdominal fat using a wet cotton swab, and move the liver to the cephalic side to fully expose the stomach and bowels.
  4. The stomach and pylorus are below the liver, and the ligament of Treitz is at the distal duodenum. Double ligate the jejunum, 5 cm distal to the ligament of Treitz with a 6-0 silk suture (Figure 1A). Cut the jejunum at the midpoint of the two ligations and suture the jejunal stump with a 10-0 silk suture (Figure 1B).
    NOTE: Avoid twisting the mesenteric blood vessels.
  5. Pull the proximal jejunal incision 5 cm along the bowel to the jejunum to create a jejunal-jejunal anastomosis. Align the two bowels horizontally, and then use a 10-0 silk suture to create the lateral anastomosis (Figure 1C).
    NOTE: During surgery, keep the bowel moist with saline to reduce water loss. This will prevent the bowel from curling up and will make suturing easier.
  6. Secure both ends of the bowel and cut the incision to equal length (Figure 1D). Suture the second layer of the posterior intestinal wall with a full-thickness continuous suture.
    NOTE: The incision length is approximately 0.5-0.6 cm, and the needle distance is ~0.5 mm.
  7. Secure both ends of the bowel and suture the anterior wall of the bowel. Suture the first layer of the anterior wall with a simple continuous suture and the second layer with a horizontal varus suture (Figure 1E-F).
    NOTE: Swab the intestinal contents with cotton swabs to prevent infection of the abdominal cavity.
  8. Pull the distal jejunal incision into the duodenum 1 cm below the pylorus to create a duodenal-jejunal anastomosis (Figure 1G). Suture it using the same method as in steps 2.6-2.7 (Figure 1H-K).
    NOTE: Check the suture at the anastomotic corner to reduce anastomotic leakage.
  9. Ligate the bowel with the micro forceps and cut the bowel with the micro scissors. Double ligate the duodenum with a 6-0 silk suture, 2 mm from the distal end of the duodenal-jejunal anastomosis. Cut at the midpoint with micro scissors and suture the stump with a 10-0 silk suture (Figure 1L).
    NOTE: The gastroduodenal vessels branch perpendicular to the head of the pancreas and are adjacent to the pylorus, requiring careful exploration of the vessels in the transverse section. The confluence of the common bile duct and duodenum was located, taking care not to damage the pancreas or the common bile duct.
  10. Rinse the abdominal cavity with 30 °C saline. Return the bowel to the abdominal cavity. Suture the muscle and the skin separately with a 6-0 silk. Then, disinfect the skin with iodophor.
  11. After surgery, inject 30 °C saline (30 mL/kg) subcutaneously in the back to prevent dehydration. Inject penicillin (10 mg/kg) intramuscularly to prevent infection.

Figure 1
Figure 1: Duodenal-jejunal bypass procedure. (A) Location of the jejunum 5 cm distal to the ligament of Treitz. (B) Double ligate the jejunum with 6-0 silk, cut through the middle of the ligature. (C) Jejunal-jejunal anastomosis. (D) Make a 0.5-0.6 cm incision, and suture the posterior wall. (E-F) Complete Jejunal-jejunal anastomosis. (G) Pull the distal jejunal to the duodenum 1 cm below the pylorus. (H) Duodenal-jejunal anastomosis. (I) Cut the duodenal-jejunal anastomosis with a 0.5-0.6 cm incision and suture the posterior wall with a simple continuous suture. (J-K) Complete duodenal-jejunal anastomosis. (L) At 2 mm from the distal to the duodenal-jejunal anastomosis, double ligate the duodenum with 6-0 silk and cut through the middle of the ligature. Please click here to view a larger version of this figure.

3. General postoperative care

  1. After surgery, place the mice on an electric blanket to prevent hypothermia. Allow the mice to crawl freely until fully awake before returning to their cages.
  2. On the postoperative day, restrict the food and water and inject 2 mL of saline subcutaneously into the back of the mice. On the first postoperative day, give 10 mL of 10% glucose and a functional drink (1:1 ratio) without food, and inject 1 mL of saline subcutaneously.
  3. On the second and third postoperative days, feed the mice with a mixture of 20 mL of 10% glucose and a functional drink. After the fourth day, give the mice pure water and a high-fat diet. Transitional feeding should be performed according to the postoperative recovery status in the following order: solution, semi-liquid, or solid food.
  4. Postoperative analgesia: inject buprenorphine (0.1 mg/kg) every 12 h from Days 1 to 3, and then once daily until Day 5.
  5. After surgery, observe the feeding conditions, activity, feces, and wound healing of the mice.

Figure 2
Figure 2: The diagram of DJB surgery. (A) Duodenal-jejunal anastomosis. (B) Jejunal-jejunal anastomosis. (C) Biliopancreatic limb. (D) Digestive limb. (E) Common limb. Please click here to view a larger version of this figure.

Figure 3
Figure 3: Anatomy of DJB surgery. (A) Duodenal-jejunal anastomosis. (B) Jejunal-jejunal anastomosis. (C) Biliopancreatic limb. (D) Digestive limb. (E) Common limb. Please click here to view a larger version of this figure.

4. Postoperative evaluation of metabolic parameters

  1. Body weight measurement
    1. Fast the mice for 8 h prior to the measurement. Weigh the mice weekly on Monday before and after surgery for 8 weeks.
  2. Food intake measurement
    1. House one mouse in each cage. Measure the amount of solid food in each cage before and after 24 h. The difference between the two values represents daily food intake.
  3. Random blood glucose measurement
    1. At 8:00 a.m. on the weekly Monday of measurement, collect a drop of blood from the tip of the mouse tail and apply it to a glucose strip inserted into the glucometer.
  4. Oral glucose tolerance test
    1. Eight weeks after the DJB surgery, fast the mice for 8 h before the oral glucose tolerance test. Collect a drop of blood from the tip of the mouse tail and place it on a glucose strip inserted into the glucometer. Administer an oral dose of 20% D-glucose (2 g/kg). Measure the blood glucose levels at 0, 15, 30, 60, 90, 120, 150, and 180 mins after gavage.

Representative Results

General conditions
The mean operative time for the DJB procedure was 84.5 ± 2.6 min. Fifteen mice underwent DJB surgery, nine mice survived. As shown in Table 1, the majority of deaths occurred during surgery or in the following 7 days. The causes of postoperative death were bleeding (n=2) on postoperative day 1, anastomotic leakage (n=1) on postoperative day 4, anastomotic obstruction (n=2) on postoperative day 7, and unknown cause (n=1) three weeks after surgery.

For 8 weeks prior to this experiment, we performed DJB surgery on 10 mice weekly as a pre-experiment to simplify the operation. As shown in Figure 4, we obtained a trend of the weekly survival rate of the mice during the pre-experiment. We observed a progressive improvement in the survival rate, indicating that intensive surgical training is required to master the DJB technique.

Figure 4
Figure 4: The survival rate of mice seven days after the DJB Surgery. The data show the benefit of the pre-experiment on the survival rate of DJB mice. The data are shown as the survival rate 7 days post-surgery (%). Please click here to view a larger version of this figure.

Body weight, food intake, and glucose homeostasis
The mice had similar body weights and food intakes before surgery and 8 weeks after surgery. DJB mice showed no significant weight loss compared to the sham control mice at 8 weeks after surgery (P > 0.05; Figure 5A). Daily food intake was reduced after the 7 days following DJB and sham control surgery and returned to preoperative levels 3 weeks later (P > 0.05; Figure 5B). We have observed improvements in fasting blood glucose levels and glucose tolerance after DJB surgery (P < 0.01; Figure 5C, 5D).

Figure 5
Figure 5: Effect of DJB on body weight, daily food intake, random blood glucose, and oral glucose tolerance test. The data are shown as the mean ± SD, n=6. ns: not significant; ** p <0.01 (Mann-Whitney and ANOVA tests). Please click here to view a larger version of this figure.

Discussion

In 1953, Varco et al.18 performed the first jejuno-ileal bypass as the beginning of bariatric surgery. Since then, numerous bariatric surgeries have been performed by surgeons. These surgeries have resulted in weight loss and improved metabolic complications4,19,20. Furthermore, in 1967, Mason and Ito21 performed the first Roux-en-Y gastric bypass (RYGB), which can effectively reduce weight and improve metabolic syndrome. Similar to RYGB, DJB is a stomach-preserving deformation of RYGB that divides the small intestine into the biliopancreatic, digestive, and common limbs. DJB surgery provides significantly durable glycemic control without relying on reduced food intake or weight loss22,23. Therefore, DJB has been recommended as a suitable bariatric surgery for type 2 diabetics with low body mass index24.

The development of bariatric surgery is inseparable from the study of animal models, and most researchers have performed DJB in rats25,26. To date, few studies have used a mouse model to study DJB despite its suitability for studying changes in metabolic indicators after intestinal reconstruction27. The paucity of such studies is due to the fact that surgical models of DJB cannot fully replicate human procedures, making it difficult to compare results between different research groups28. Liang et al.29 initially demonstrated the significant therapeutic effect of DJB surgery on obesity and T2DM in db/db mice. The duodenum was double ligated with 5-0 suture, transected 2 mm distal to the pylorus, cut 4-5 cm below the ligament of Treitz, and the distal jejunum was sutured to the pylorus with a single interrupted end-to-end suture of 9-0 silk thread. The opening of the biliopancreatic limb was sutured with 9-0 silk ~4 cm distal to the jejunal anastomosis. Barataud et al. have also successfully established a mouse model of DJB using db/db mice30. Therefore, in our study, the small bowel was transected 5 cm below the ligament of Treitz. A jejunojejunostomy was performed on the distal 5 cm of the small bowel. The distal jejunum and duodenum were then sutured.

As shown in Table 1, the mice were divided into DJB (n=15) and sham surgery (n=7), nine mice survived in the DJB group, with a survival rate of 60.0%. We have also shown the dead cases and percentage of postoperative deaths in each group. As shown in Table 2, to increase the success rate of this technique, we have continuously improved each step. Intestinal anastomotic bleeding is the most common type of postoperative bleeding, and this complication is the leading cause of death. Therefore, the operation must be performed carefully. An intestinal incision was made at the anti-intestinal mesenteric border to keep away from the blood vessels. In our study, the anastomotic leakage was duodenojejunal anastomosis, which may be due to excessive tension in the anastomosis. Anastomotic leakage has been observed in the duodenal intestinal stump. Therefore, the corners of the anastomosis should be carefully checked during surgery, and if the suture is inadequate, the suture can be used for reinforcement. The suture distance should not be excessively long to reduce anastomotic leakage. Anastomotic obstruction was observed in the jejunal-jejunal anastomosis. Due to the unique physiological structure of the intestine in mice, the small bowel was easily twisted. The anastomotic stoma was shorter than expected when the sutures were pulled tight. During the operation, the mesentery should be adequately dissected, and the bowel should be smoothed out as much as possible to provide enough space for the placement. We should also take care of the suture tightness and the size of the anastomosis.

The main limitation of this DJB technique is that it is performed in mice. The use of microscopic equipment is becoming increasingly important in the establishment of DJB mouse models, as it provides a clear surgical field of view31,32,33. After extensive preliminary experiments, we were familiar with the anatomical structures involved in the surgical procedure and were able to skillfully perform microsurgical manipulations with improved suture precision, reduced surgical injury, and significantly shortened surgical time, thereby enabling DJB surgery in mice. However, the skilled operation of microscopic instruments is a gradual process. We analyzed the causes of death in mice in order to improve the surgical procedure, including shortening the surgical and postoperative recovery times, strengthening the postoperative feeding management, and improving the overall survival rate of the mice.

In conclusion, the application of this surgery in mice allows for a better understanding of the mechanisms underlying the powerful metabolic effects of this procedure. We believe that our study provides a solid foundation for further improving the application of DJB in the treatment of diabetes.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This study was supported by a grant from the Science and Technology Planning Project of Guangdong Province of China (No. 202002020069).

Materials

Abdominal retractor F.S.T 17000-03 Colibri Retractor -3cm,retractor range 1.5cm/3cm long
1% sodium pentobarbital solution Guangzhou Chemical Reagent Factory /  Dissolved 500mg of pentobarbital sodium powder in 50ml of normal saline to obtain 1% pentobarbital sodium solution.
Benzylpenicillin sodium for Injection North China Pharmaceutical Company Ltd. F2062121 Penicillin
Buprenorphine Guangzhou Chemical Reagent Factory / Analgesia
Buprenorphine Guangzhou Otsuka Pharmaceutical Co., Ltd / Analgesic
Citric acid-sodium citrate buffer LEAGENE R00522 Buffer solution
Cotton buds HaoZheng Medical 60220610 Cotton swabs
Depilatory paste Veet AAPR-S222 Hair removal cream
Ear tag ZEYA SUS304 Ear-mark
Electric blanket ZOSEN ZS-CWDRT Heat pad
Electronic scale WETTLER TOLEDO 20060902-6 Measure the weight
Enteral nutritional powder Abbott Laboratories / Nutrition powder
Eye ointment Guangzhou Otsuka Pharmaceutical Co., Ltd / Protect the eyes
Glucometer Roche 6993788001 Assess blood glucose
Graphpad Prism version 9.4.1 GraphPad Software version 9.4.1 Software for statistical analysis
High-fat diet (High Fat [60FDC] Purified Rodent Diet) Dyets 112252 60kcal% High Fat Diet
Micro Forceps Jinzhong Medical 18-1140 Micro forceps
Micro needle holder Jinzhong Medical EMT-160-Z Needle holder
Micro Scissors Jinzhong Medical YBC010 Micro scissors
Microscope camera LAPSUN E 2000 Video
Ophthalmic scissors Jinzhong Medical Y00030 Surgical scissors
Pentobarbital Guangzhou Chemical Reagent Factory / Narcosis
Sodium chloride Injection Guangzhou Otsuka Pharmaceutical Co., Ltd B21L0301 NaCl 0.9%
Stereo microscope ZEISS Stemi 305 Binocular stereomicroscope
Streptozotocin Sigma S110910-1g STZ
Suture line LINGQIAO SUTURE ZS-LQPMRZ5/0 Prolene 6/0,Prolene 10/0
Tissue forceps Jinzhong Medical H1701 Surgical forceps
DOWNLOAD MATERIALS LIST

References

  1. Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., Bellary, .S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 6 (1), 69-80 (2018).
  2. Song, Y., Zhao, F. Bibliometric analysis of metabolic surgery for type 2 diabetes: current status and future prospects. Updates Surg. 74 (2), 697-707 (2022).
  3. Cummings, D. E., Rubino, F. Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia. 61 (2), 257-264 (2018).
  4. Buchwald, H. The evolution of metabolic/bariatric surgery. Obes Surg. 24 (8), 1126-1135 (2014).
  5. Akalestou, E., Miras, A. D., Rutter, G. A., le Roux, C. W. Mechanisms of weight loss after obesity surgery. Endocr Rev. 43 (1), 19-34 (2022).
  6. Rubino, F. et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 244 (5), 741-749 (2006).
  7. Rubino, F., Marescaux, J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 239 (1), 1-11 (2004).
  8. Akalestou, E., et al. Establishing a successful rat model of duodenal- jejunal bypass: A detailed guide. Lab Anim. 53 (4), 362-371 (2019).
  9. Yu, H. H., Hsieh, M. C., Wu, S. Y., Sy, E. D., Shan, Y. S. Effects of duodenal-jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats. Diabetes Metab Syndr Obes. 12, 149-159 (2019).
  10. Garciacaballero, M., Navarrete, S., Favretti, F., Celik, A., Del Castillo, D. Diabetes surgery in type 2 BMI 24-29 vs IMC 30-34 diabetic patients: is there differences among restrictive, malabsorptive and gastric bypass procedures? Nutr Hosp. 28 Suppl 2:23-30 (2013).
  11. Vidal, J., Jiménez, A. Diabetes remission following metabolic surgery: is GLP-1 the culprit? Curr Atheroscler Rep. 15 (10):357 (2013).
  12. Speck, M., Cho, Y. M., Asadi, A., Rubino, F., Kieffer, T. J. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. Am J Physiol Endocrinol Metab. 300 (5), E923-932 (2011).
  13. Ashrafian, H. et al. Metabolic surgery: an evolution through bariatric animal models. Obes Rev. 11(12), 907-920 (2010).
  14. Rao, R. S., Rao, V., Kini, S. Animal models in bariatric surgery–a review of the surgical techniques and postsurgical physiology. Obes Surg. 20 (9), 1293-1305 (2010).
  15. Im, Y. R. et al. A systematic review of animal models of NAFLD finds high-fat, high-fructose diets most closely resemble human NAFLD. Hepatology. 74 (4), 1884-1901 (2021).
  16. Kleinert, M. et al. Animal models of obesity and diabetes mellitus. Nat Rev Endocrinol. 14 (3), 140-162 (2018).
  17. Furman, B. L. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 1 (4):e78 (2021).
  18. Buchwald, H., Varco, R. L., Moore, R. B., Schwartz, M. Z. Intestinal bypass procedures. Partial ileal bypass for hyperlipidemia and jejunoileal bypass for obesity. Curr Probl Surg. 1-51 (1975).
  19. DeMaria, E. J. Bariatric surgery for morbid obesity. N Engl J Med. May 24;356(21):2176-2183 (2007).
  20. Bolling, C. F., Armstrong, S. C., Reichard, K. W., Michalsky, M. P. Metabolic and bariatric surgery for pediatric patients with severe obesity. Pediatrics. 144 (6), e20193224 (2019).
  21. Mason, E. E. Gastric bypass for morbid obesity. Surg Annu. 11, 99-126 (1979).
  22. Cheng, Y. et al. Sleeve gastrectomy with bypass of proximal small intestine provides better diabetes control than sleeve gastrectomy alone under postoperative high-fat diet. Obes Surg. 29 (1), 84-92 (2019).
  23. Rubino, F. et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology. 146 (4), 1745-1751 (2005).
  24. Zachariah, P. J. et al. Compared to sleeve gastrectomy, duodenal-jejunal bypass with sleeve gastrectomy gives better glycemic control in T2DM patients, with a lower β-cell response and similar appetite sensations: mixed-meal study. Obes Surg. 26 (12), 2862-2872 (2016).
  25. Jiang, B., et al. Role of proximal intestinal glucose sensing and metabolism in the blood glucose control in type 2 diabetic rats after duodenal jejunal bypass surgery. Obes Surg. 32 (4), 1119-1129 (2022).
  26. Han, H. F. et al. Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats. World J Gastroenterol. 28 (31), 4338-4350 (2022).
  27. Yan, S., et al. Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse model. Obes Surg. 23 (9), 1361-1369 (2013).
  28. Arble, D. M. et al. Metabolic comparison of one-anastomosis gastric bypass, single-anastomosis duodenal-switch, Roux-en-Y gastric bypass, and vertical sleeve gastrectomy in rat. Surg Obes Relat Dis. 14 (12), 1857-1867 (2018).
  29. Liang, Y. et al. Duodenal-jejunal bypass surgery reverses diabetic phenotype and reduces obesity in db/db Mice. Curr Chem Genom Transl Med. 11, 41-49 (2017).
  30. Barataud, A. et al. Absence of role of dietary protein sensing in the metabolic benefits of duodenal-jejunal bypass in the mouse. Sci Rep. 7, 44856 (2017).
  31. Close-up on lab animal microsurgery. Lab Anim (NY). 35(1), 43 (2006).
  32. Couceiro, J., Castro, R., Tien, H., Ozyurekoglu, T. Step by step: microsurgical training method combining two nonliving animal models. J Vis Exp. (99), e52625 (2015).
  33. Nasser, K. M., Wahba, H. A., Kamal, E., El-Makhzangy, A. M., Bahaa, N. Animal model for training and improvement of the surgical skills in endolaryngeal microsurgery. J Voice. 26 (3), 351-357 (2012).

Play Video
PDF
DOI
DOWNLOAD MATERIALS LIST
Cite This Article
He, J., Li, H., Dai, X., Xie, Z., Song, Z., Chen, X., Huang, H., Ding, Y., Qi, T., Liu, Q., Zhang, H., Wu, L. Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice. J. Vis. Exp. (212), e66049, doi:10.3791/66049 (2024).
Download Citation
Reprints and Permissions

View Video

✖

To prove you're not a robot, please enter the text in the image below

CAPTCHA Image
Play CAPTCHA Audio
Refresh Image